Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy

Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy

We’ve got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode! 

Show Notes:

Subscribe:

The BloodStream Podcast

 

Presenting Sponsor:

Takeda, visit bleedingdisorders.com to learn more.

Connect with BloodStream Media:

BloodStreamMedia.com

BloodStream on Facebook 

BloodStream on Twitter

Keith Korneluk